J&J settles Ohio opioid lawsuits for $20.4M

Oct. 3, 2019

Johnson & Johnson has agreed to a $20.4 million settlement to avoid going to trial over the opioid-addiction crisis in two Ohio counties.

J&J is the fourth drugmaker to reach a deal ahead of a trial in Cuyahoga and Summit counties. Earlier this week, Mallinckrodt also struck a $30 million deal with the two counties. Endo International previously agreed to pay the counties $10 million, while Allergan agreed to pay $5 million to avoid trial.

J&J's deal includes no admission of liability. According to the drugmaker, the settlement allows it to "avoid the resource demands and uncertainty of a trial as it continues to seek meaningful progress in addressing the nation’s opioid crisis.”

Read the WSJ coverage